Dave Singh Selected Research

Beclomethasone (Beclometasone)

4/2022	Normalisation of airflow limitation in asthma: Post-hoc analyses of TRIMARAN and TRIGGER.
1/2022	Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone.
3/2021	Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.
1/2021	Extrafine triple therapy and asthma exacerbation seasonality: TRIMARAN and TRIGGER post hoc analyses.
12/2020	The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD.
10/2020	Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER.
1/2020	Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study.
1/2019	Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler.
8/2018	Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease.
1/2018	Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dave Singh Research Topics

Disease

229	Chronic Obstructive Pulmonary Disease (COPD) 09/2022 - 01/2007
77	Asthma (Bronchial Asthma) 08/2022 - 07/2007
42	Inflammation (Inflammations) 03/2022 - 08/2006
18	Pneumonia (Pneumonitis) 03/2022 - 05/2009
10	COVID-19 01/2022 - 01/2020
8	Chronic Bronchitis 11/2021 - 10/2016
7	Dyspnea (Shortness of Breath) 01/2020 - 01/2012
6	Infections 01/2020 - 07/2014
5	Emphysema 01/2021 - 06/2011
5	Necrosis 03/2020 - 02/2014
4	Respiratory Tract Diseases (Respiratory Tract Disease) 10/2021 - 01/2012
4	Obstructive Lung Diseases (Obstructive Lung Disease) 03/2021 - 01/2017
4	Headache (Headaches) 01/2020 - 01/2011
4	Lung Diseases (Lung Disease) 01/2019 - 02/2010
3	Respiratory Hypersensitivity 01/2021 - 01/2019
3	Virus Diseases (Viral Diseases) 07/2020 - 07/2014
3	Fatigue 12/2016 - 01/2011
2	Disease Progression 01/2022 - 01/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

88	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 10/2008
53	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 01/2007
46	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2009
38	Formoterol Fumarate (Oxis)FDA Link 04/2022 - 01/2011
35	Muscarinic AntagonistsIBA 02/2022 - 01/2012
25	GoldIBA 01/2021 - 10/2009
24	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2022 - 01/2012
22	Beclomethasone (Beclometasone)FDA Link 04/2022 - 03/2012
22	CytokinesIBA 10/2021 - 05/2008
18	vilanterolIBA 01/2022 - 08/2015
18	GSK573719IBA 01/2022 - 08/2015
18	Tiotropium Bromide (Spiriva)FDA Link 03/2021 - 08/2010
15	Proteins (Proteins, Gene)FDA Link 07/2020 - 01/2009
13	fluticasone furoate FDA Link 01/2022 - 05/2018
13	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 02/2009
12	p38 Mitogen-Activated Protein KinasesIBA 08/2021 - 02/2009
11	Anti-Bacterial Agents (Antibiotics)IBA 09/2022 - 10/2012
11	Phosphodiesterase 4 InhibitorsIBA 11/2021 - 03/2010
10	Biological ProductsIBA 01/2022 - 02/2014
10	Pharmaceutical PreparationsIBA 01/2021 - 02/2008
10	GlucocorticoidsIBA 01/2020 - 09/2008
10	SmokeIBA 01/2019 - 05/2008
8	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 11/2014
8	AllergensIBA 01/2020 - 11/2007
8	LipopolysaccharidesIBA 01/2018 - 02/2009
7	indacaterolIBA 02/2022 - 01/2011
7	Fluticasone (Cutivate)FDA LinkGeneric 01/2022 - 07/2007
7	Monoclonal AntibodiesIBA 01/2022 - 10/2008
7	aclidinium bromideIBA 01/2021 - 10/2012
7	tanimilastIBA 01/2021 - 01/2019
7	tiotropium-olodaterolIBA 01/2021 - 10/2015
7	LigandsIBA 08/2019 - 02/2014
6	Albuterol (Salbutamol)FDA LinkGeneric 04/2022 - 10/2012
6	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2009
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 08/2006
6	Salmeterol Xinafoate (Serevent)FDA Link 01/2021 - 07/2007
6	SteroidsIBA 01/2021 - 11/2007
6	Interleukin-13IBA 01/2021 - 01/2010
6	Methacholine Chloride (Methacholine)FDA Link 01/2020 - 10/2012
5	RoflumilastIBA 11/2021 - 10/2016
5	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2021 - 10/2016
5	16S Ribosomal RNAIBA 01/2021 - 01/2017
5	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021 - 10/2014
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2009
4	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2020
4	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2021 - 11/2009
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 05/2011
4	Oxygen (Dioxygen)IBA 01/2021 - 11/2014
4	ensifentrineIBA 02/2020 - 11/2013
4	ChemokinesIBA 11/2019 - 05/2008
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 01/2013
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 08/2015 - 01/2011
4	Interleukin-8 (Interleukin 8)IBA 10/2013 - 05/2009
3	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2014
3	AZD-8871IBA 01/2022 - 01/2019
3	IronIBA 12/2021 - 01/2020
3	EnzymesIBA 12/2021 - 01/2017
3	Janus Kinase InhibitorsIBA 11/2021 - 10/2016
3	Phosphotransferases (Kinase)IBA 11/2021 - 01/2016
3	InterleukinsIBA 10/2021 - 08/2015
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2021 - 09/2014
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2021 - 04/2020
3	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2019
3	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 01/2021 - 10/2019
3	Immunoglobulin E (IgE)IBA 01/2021 - 01/2018
3	doramapimodIBA 01/2020 - 01/2017
3	Chemokine ReceptorsIBA 11/2017 - 10/2008
3	CXC ChemokinesIBA 08/2015 - 02/2014
3	Volatile Organic CompoundsIBA 08/2012 - 02/2010
2	AntioxidantsIBA 08/2022 - 01/2018
2	Adenosine Monophosphate (AMP)IBA 11/2021 - 01/2021
2	nezulcitinibIBA 11/2021 - 10/2021
2	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 10/2021 - 08/2019
2	Fibrinogen (Factor I)FDA Link 04/2021 - 02/2015
2	Acetates (Acetic Acid Esters)FDA Link 04/2021 - 01/2021

Therapy/Procedure

81	Therapeutics 03/2022 - 10/2008
35	Nebulizers and Vaporizers (Inhaler) 03/2022 - 07/2007
6	Metered Dose Inhalers (Metered Dose Inhaler) 01/2021 - 01/2017
3	Dry Powder Inhalers 01/2021 - 01/2019
3	Precision Medicine 01/2021 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2016 - 03/2012